---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-034743"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T13:20:24.608192+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q2 revenue falls 43% to $168.6M; net loss $0.75/share, guides Q3 loss

## Summary
- Revenue $168.6M, down 43.1% YoY; active earning Coaches 33,900 (-36.2%); avg revenue per Coach $4,972 (-10.9%).
- GAAP net loss $8.2M ($0.75 loss per diluted share); non-GAAP adjusted net income $10.1M ($0.92 EPS).
- Q3 2024 revenue guidance $125M-$145M; diluted loss per share expected $0.05-$0.70.
- Cash, equivalents and securities $163.5M; no debt; CEO cites transformation and LifeMD collaboration.
- Gross margin improved to 73.2% (non-GAAP 74.8%); SG&A rose to 77.9% of revenue due to fixed-cost deleverage.

## SEC filing metadata
- accession: 0001628280-24-034743
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828024034743/0001628280-24-034743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828024034743/med-20240805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-034743
- JSON: https://secwatch.observer/filing/0001628280-24-034743.json
- Plain text: https://secwatch.observer/filing/0001628280-24-034743.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.